Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer

被引:131
|
作者
Stoehr, R
Wissmann, C
Suzuki, H
Knuechel, R
Krieg, RC
Klopocki, E
Dahl, E
Wild, P
Blaszyk, H
Sauter, G
Simon, R
Schmitt, R
Zaak, D
Hofstaedter, F
Rosenthal, A
Baylin, SB
Pilarsky, C
Hartmann, A
机构
[1] Univ Basel, Inst Pathol, CH-4031 Basel, Switzerland
[2] Univ Regensburg, Inst Pathol, D-8400 Regensburg, Germany
[3] metaGen Pharmaceut GmbH, Berlin, Germany
[4] Johns Hopkins Univ, S Kimmel Compreh Canc Ctr, Baltimore, MD USA
[5] Rhein Westfal TH Aachen, Univ Clin, Inst Pathol, Aachen, Germany
[6] Univ Vermont, Inst Pathol, Burlington, VT 05405 USA
[7] Univ Regensburg, Dept Genet, D-8400 Regensburg, Germany
[8] Univ Munich, Dept Urol, Munich, Germany
关键词
bladder cancer; chromosome; 8; sFRP1; TMA; LOH; promoter methylation;
D O I
10.1038/labinvest.3700068
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Many molecular alterations are known to occur in urothelial carcinoma of the bladder, but their significance for tumor progression is poorly understood. Deletions of chromosome 8p are frequently found in several tumor types and are often associated with progressive disease. In all, 99 bladder tumors were screened for deletions at 8p using loss of heterozygosity (LOH) and multicolor fluorescence in situ hybridization FISH analyses. Allelic loss on chromosome 8p in at least one marker was found in 25/99 (25%) tumors. There was a significant correlation of 8p deletions with invasive tumor growth and a highly significant association with papillary growth pattern in patients with invasive disease. cDNA array analyses revealed that secreted Frizzled-related protein 1 (sFRP1), an antagonist of Frizzled receptors and Wnt pathway activation on chromosome 8p12-11.1, is frequently downregulated in bladder cancer. To investigate sFRP1 as a candidate for a putative progression-related gene on 8p, urothelial cell lines and primary urothelial carcinomas were screened for sFRP1 expression using quantitative real-time PCR, Northern blot, immunofluorescence and immunohistochemistry (IHC). Of the investigated bladder cancers, 38% showed loss of sFRP1 expression by quantitative RT-PCR. Evaluation of the protein expression by IHC using tissue microarrays containing 776 bladder cancers revealed loss or strong reduction of sFRP1 expression in 66% of cases. SFRP1 loss was associated with higher tumor stage and grade and shorter overall survival. In addition, loss of sFRP1 was an independent indicator of poor survival in patients with papillary but not with muscle invasive bladder cancer. There were neither mutations in the coding region of sFRP1 nor homozygous deletions at 8p12-11.21. However, promoter methylation was detected using methylation-specific PCR in 29% of cases. In conclusion, we could show a close correlation of chromosome 8p deletions and progression of papillary bladder tumors. The sFRP1 gene on chromosome 8p12-11.1 could be a candidate gene for the predicted, progression-related tumor suppressor gene in bladder cancer and could contribute to urothelial carcinogenesis.
引用
收藏
页码:465 / 478
页数:14
相关论文
共 26 条
  • [1] Functional analyses and prognostic significance of SFRP1 expression in bladder cancer
    Rogler, Anja
    Kendziorra, Emil
    Giedl, Johannes
    Stoehr, Christine
    Taubert, Helge
    Goebell, Peter J.
    Wullich, Bernd
    Stoeckle, Michael
    Lehmann, Jan
    Petsch, Sabrina
    Hartmann, Arndt
    Stoehr, Robert
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) : 1779 - 1790
  • [2] Aberrant loss of SFRP1 expression is associated with poor prognosis in pancreatic cancer
    Jiang, Nan
    Hu, Ming-Gen
    Tang, Wen-Bo
    Yin, Zhu-Zeng
    Wang, Zi-Zheng
    Liu, Qu
    Liu, Rong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (05): : 6064 - 6070
  • [3] Functional analyses and prognostic significance of SFRP1 expression in bladder cancer
    Anja Rogler
    Emil Kendziorra
    Johannes Giedl
    Christine Stoehr
    Helge Taubert
    Peter J. Goebell
    Bernd Wullich
    Michael Stöckle
    Jan Lehmann
    Sabrina Petsch
    Arndt Hartmann
    Robert Stoehr
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1779 - 1790
  • [4] Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer
    Stoehr, R
    Zietz, S
    Burger, M
    Filbeck, T
    Denzinger, S
    Obermann, EC
    Hammerschmied, C
    Wieland, WF
    Knuechel, R
    Hartmann, A
    EUROPEAN UROLOGY, 2005, 47 (01) : 58 - 63
  • [5] Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis
    Liang, Cher-Wei
    Yang, Ching-Yao
    Flavin, Richard
    Fletcher, Jonathan A.
    Lu, Tzu-Pin
    Lai, I-Rue
    Li, Yu-I
    Chang, Yih-Leong
    Lee, Jen-Chieh
    HUMAN PATHOLOGY, 2021, 107 : 69 - 79
  • [6] ALLELIC LOSS AT CHROMOSOME 8P IN HUMAN BREAST-CANCER
    KERANGUEVEN, F
    ADELAIDE, J
    DIB, A
    LONGY, M
    LIDEREAU, R
    PEBUSQUE, MJ
    JACQUEMIER, J
    BIRNBAUM, D
    ONCOLOGY REPORTS, 1994, 1 (02) : 393 - 395
  • [7] Allelic imbalance at chromosomes 5q, 8p and 17p as progression markers for bladder cancer?
    von Knobloch, R
    Schullerus, D
    Riedmiller, H
    Kälble, T
    AKTUELLE UROLOGIE, 2000, 31 : 83 - 86
  • [8] Loss of SFRP1 Expression is Associated with Aberrant β-Catenin Distribution and Tumor Progression in Mucoepidermoid Carcinoma of Salivary Glands
    Lee, Chien-Hsing
    Hung, Yi-Jen
    Lin, Chih-Yuan
    Hung, Pei-Hsin
    Hung, Hsing-Wen
    Shieh, Yi-Shing
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) : 2237 - 2246
  • [9] Deletion mapping implicates two tumour suppressor genes on chromosome 8p in the development of bladder cancer
    Takle, LA
    Knowles, MA
    ONCOGENE, 1996, 12 (05) : 1083 - 1087
  • [10] Numerical aberrations of chromosome 8 and allelic loss at 8p in non-muscle-invasive urothelial carcinomas of the urinary bladder
    Erbersdobler, A
    Kaiser, H
    Friedrich, MG
    Henke, RP
    EUROPEAN UROLOGY, 2000, 38 (05) : 590 - 596